Skip to main content
Clinical Trials/ACTRN12619000642189
ACTRN12619000642189
Terminated
未知

A Pilot Randomised Controlled Trial Investigating the Effects of Cognitive Behavioural Therapy for Insomnia (CBT-I) with and without Imagery Rehearsal Therapy (IRT) on Sleep Quality for Ex-Service Personnel with Insomnia and Nightmares in the Context of Posttraumatic Stress Disorder (PTSD) and Obstructive Sleep Apnoea (OSA)

Gallipoli Medical Research Foundation0 sites30 target enrollmentApril 30, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Gallipoli Medical Research Foundation
Enrollment
30
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 30, 2019
End Date
March 23, 2021
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male or female ex\-serving Australian Defence Force personnel (i.e. veterans)
  • Age greater than or equal to 18 years
  • Diagnosis of PTSD: Have an accepted diagnosis of PTSD with the Australian Department of Veteran Affairs, or meet diagnostic criteria for lifetime PTSD according to the CAPS\-5
  • Insomnia: A score of greater than or equal to 15 on the ISI (clinical insomnia, moderate severity)
  • Nightmares: Distressing nightmares, with a frequency of at least 2 per month
  • Poor sleep: A score of \>5 on the PSQI
  • Stable pharmacological treatment for any condition for at least 1 month prior to baseline
  • Willingness and ability to attend CBT\-I or CBT\-I\+IRT treatment sessions as required according to study protocol

Exclusion Criteria

  • Current bipolar I disorder (presence of manic episode in the past 5 years): Meets DSM\-5 diagnostic criteria (as measured by the MINI 7\.0\), where further screening is indicated by the DSM\-5 Self\-Rated Level 1 Cross Cutting Symptom Measure\-Adult.
  • Schizophrenia: Meets DSM\-5 current diagnostic criteria (as measured by the MINI 7\.0\), where further screening is indicated by the DSM\-5 Self\-Rated Level 1 Cross Cutting Symptom Measure\-Adult.
  • Current psychosis: Meets DSM\-5 diagnostic Criterion A and B of schizophrenia diagnosis (as measured by the MINI 7\.0\), where further screening is indicated by the DSM\-5 Self\-Rated Level 1 Cross Cutting Symptom Measure\-Adult.
  • Current imminent risk of suicide, as indicated by the Columbia Suicide Severity Rating Scale
  • Unstable psychiatric condition, as indicated by hospitalisation for any psychiatric condition in the past four weeks
  • Any neurological disorder known to impact sleep (e.g., narcolepsy, Parkinson’s disease)
  • Previous diagnosis of moderate to severe traumatic brain injury (TBI) (i.e., loss of consciousness for more than 30 minutes) in the past five years
  • Females who are pregnant or breastfeeding
  • Inadequate circumstances for sleep e.g. night shift\-worker
  • Currently receiving exposure\-based, trauma\-focused therapy (e.g. prolonged exposure therapy, trauma\-focused cognitive behavioural therapy and eye movement desensitisation reprocessing (EMDR) for PTSD

Outcomes

Primary Outcomes

Not specified

Similar Trials